Cargando…
The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes
Multigene expression assays are prognostic for recurrence in hormone-receptor positive 2 (HER-2) negative breast cancer, and, in some cases, predictive of benefit from chemotherapy or extended endocrine therapy. The results of these assays may be used to guide treatment recommendations for early HER...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366126/ https://www.ncbi.nlm.nih.gov/pubmed/34408795 http://dx.doi.org/10.1177/17588359211038467 |